Medgenome Labs Limited
Medgenome Labs Limited is a Public Company limited by Shares company incorporated in 2013 and based in Karnataka, India. Medgenome Labs Limited operates in Agriculture and engineering & technology, research and experimental development (NIC 73100) with authorized capital of ₹4.50 Cr and paid-up capital of ₹2.57 Cr. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
MEDGENOME LABS LIMITED is the legal entity of Genessense, OneAssist and MedGenome.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Medgenome Labs Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +20d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Medgenome Labs Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 451317453 | Axis Bank Ltd(Bank) | ₹20.80 Cr | 27 Jan 2022 | Open |
| 770301067 | Axis Bank Ltd(Bank) | ₹16.58 Cr | 19 Sep 2020 | Open |
| 342971411 | HDFC Bank Ltd(Bank) | ₹15.90 Cr | 19 Sep 2022 | Open |
| 380833922 | Kotak Mahindra Bank Ltd(Bank) | ₹21.21 Cr | 19 Sep 2020 | Open |
| 929305322 | Kotak Mahindra Bank Ltd(Bank) | ₹20.28 Cr | 27 Jan 2021 | Open |
Charge IDs, lenders & amounts for Medgenome Labs Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹44.06 Cr | ₹3.67 Cr | ₹34.58 Cr | ₹52.42 Cr | 268 |
| FY2023-24 | ₹40.59 Cr | ₹2.82 Cr | ₹27.33 Cr | ₹42.69 Cr | 337 |
| FY2022-23 | ₹29.41 Cr | ₹2.49 Cr | ₹33.70 Cr | ₹49.38 Cr | 56 |
| FY2021-22 | ₹30.60 Cr | ₹2.15 Cr | ₹14.74 Cr | ₹33.72 Cr | 61 |
Audited financials & ratios for Medgenome Labs Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹44.06 Cr | ₹40.59 Cr | ₹29.41 Cr | ₹30.60 Cr |
| Other income | ₹30.71 L | ₹33.12 L | ₹80.76 L | ₹1.08 Cr |
| Total income | ₹44.37 Cr | ₹40.92 Cr | ₹30.22 Cr | ₹31.69 Cr |
| Total expenses | ₹39.67 Cr | ₹37.31 Cr | ₹27.04 Cr | ₹28.93 Cr |
| Profit before tax | ₹4.77 Cr | ₹3.67 Cr | ₹3.23 Cr | ₹2.80 Cr |
| Profit / (Loss) after tax | ₹3.67 Cr | ₹2.82 Cr | ₹2.49 Cr | ₹2.15 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹34.58 Cr | ₹27.33 Cr | ₹33.70 Cr | ₹14.74 Cr |
| Borrowings | ₹7.45 Cr | ₹5.33 Cr | ₹5.91 Cr | ₹7.17 Cr |
| Current liabilities | ₹7.69 Cr | ₹6.38 Cr | ₹7.00 Cr | ₹6.06 Cr |
| Total liabilities | ₹17.84 Cr | ₹15.36 Cr | ₹15.68 Cr | ₹18.98 Cr |
| Current assets | ₹19.85 Cr | ₹18.68 Cr | ₹24.94 Cr | ₹12.35 Cr |
| Cash & equivalents | ₹7.22 Cr | ₹6.25 Cr | ₹3.82 Cr | ₹1.59 Cr |
| Total assets | ₹52.42 Cr | ₹42.69 Cr | ₹49.38 Cr | ₹33.72 Cr |
| Employees | 268 | 337 | 56 | 61 |
Audited financials & ratios for Medgenome Labs Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹44.06 Cr | +9.0% | +19.7% | +19.2% |
| Profit after Tax | ₹3.67 Cr | +22.9% | +27.0% | +7.8% |
| Net Worth | ₹34.58 Cr | +12.3% | +21.9% | +1.3% |
| Employees | 268 | +11.7% | -3.4% | +20.1% |
Audited financials & ratios for Medgenome Labs Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹44.06 Cr | ₹3.67 Cr | +8.33% | +0.71% | +10.61% | +7.00% | 0.22 | ₹16.44 L |
| FY2023-24 | ₹40.59 Cr | ₹2.82 Cr | +6.95% | -12.99% | +10.32% | +6.61% | 0.20 | ₹12.05 L |
| FY2022-23 | ₹29.41 Cr | ₹2.49 Cr | +8.45% | +31.01% | +7.38% | +5.03% | 0.18 | ₹52.52 L |
| FY2021-22 | ₹30.60 Cr | ₹2.15 Cr | +7.03% | +39.75% | +14.60% | +6.38% | 0.49 | ₹50.17 L |
Audited financials & ratios for Medgenome Labs Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 3,50,72,768 | 77.55% |
| Institutional Investors | 1 | 26,70,481 | 5.90% |
| Public & Others | 16 | 74,82,601 | 16.54% |
Promoter, institutional & public holding for Medgenome Labs Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
15 peersTop 1 in Agriculture and engineering & technology, research and experimental development
by healthView all ›Events & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.